These clinical research data indicate that anti-TRIM21 antibodies seem to exist in IIM-ILD patients before any clinical symptoms appear, and they can be detected in the serum possibly even before IIM complicates with ILD, or even earlier. Here, TRIM21 is linked to acquired idiopathic inflammatory myopathy.